$TRVN
TREVENA INC Stock $trvn

$trvn Overview Financials Valuation SEC Filings Company Website

2021 Form 10-K Financial Statement

#000155837022004825 Filed on March 31, 2022

Income Statement

Concept	2021	2020 Q4	2020
Revenue	$567.0K	$70.00K	$3.069M
YoY Change	-81.52%	133.33%	9800.0%
Cost Of Revenue	$954.0K	$180.0K	$182.0K
YoY Change	424.18%
Gross Profit	-$387.0K	-$110.0K	$2.887M
YoY Change	-113.4%
Gross Profit Margin	-68.25%	-157.14%	94.07%
Selling, General & Admin	$38.11M	$8.230M	$19.25M
YoY Change	97.98%	126.1%	45.72%
% of Gross Profit			666.78%
Research & Development	$13.43M	$3.670M	$13.12M
YoY Change	2.3%	28.32%	-1.26%
% of Gross Profit			454.59%
Depreciation & Amortization	$400.0K	$110.0K	$500.0K
YoY Change	-20.0%	-15.38%	-16.67%
% of Gross Profit			17.32%
Operating Expenses	$13.43M	$11.90M	$13.12M
YoY Change	2.3%	83.08%	-1.26%
Operating Profit	-$51.93M	-$12.01M	-$29.49M
YoY Change	76.11%		10.93%
Interest Expense	$1.000K	$90.00K	$29.00K
YoY Change	-96.55%	-228.57%	-96.89%
% of Operating Profit
Other Income/Expense, Net	$337.0K	$50.00K	$416.0K
YoY Change	-18.99%	-50.0%	-75.66%
Pretax Income	-$51.59M	-$11.87M	-$29.07M
YoY Change	77.47%	84.03%	16.88%
Income Tax	$0.00	$0.00	$300.0K
% Of Pretax Income
Net Earnings	-$51.59M	-$11.87M	-$29.37M
YoY Change	75.65%	84.03%	18.09%
Net Earnings / Revenue	-9098.41%	-16957.14%	-956.96%
Basic Earnings Per Share	-$0.32		-$0.23
Diluted Earnings Per Share	-$0.32	-$93.01K	-$0.23
COMMON SHARES
Basic Shares Outstanding	163.3M	157.0M	127.6M
Diluted Shares Outstanding	163.3M		127.6M

Balance Sheet

Concept	2021	2020 Q4	2020
SHORT-TERM ASSETS
Cash & Short-Term Investments	$66.92M	$109.4M	$109.4M
YoY Change	-38.83%	205.54%	205.59%
Cash & Equivalents	$66.92M	$109.4M	$109.4M
Short-Term Investments		$0.00	$0.00
Other Short-Term Assets	$1.448M	$600.0K	$600.0K
YoY Change	141.33%	-64.71%	-64.71%
Inventory	$2.352M
Prepaid Expenses
Receivables	$0.00	$71.00K	$100.0K
Other Receivables	$0.00	$9.000M	$9.000M
Total Short-Term Assets	$70.72M	$119.0M	$119.0M
YoY Change	-40.57%	217.55%	217.33%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.547M	$2.253M	$7.400M
YoY Change	-11.53%	-16.71%	-9.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.854M	$13.00K	$1.300M
YoY Change	119.54%	-35.0%	0.0%
Total Long-Term Assets	$9.401M	$8.695M	$8.700M
YoY Change	8.06%	-8.53%	-8.42%
TOTAL ASSETS
Total Short-Term Assets	$70.72M	$119.0M	$119.0M
Total Long-Term Assets	$9.401M	$8.695M	$8.700M
Total Assets	$80.12M	$127.7M	$127.7M
YoY Change	-37.26%	171.82%	171.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.547M	$1.693M	$1.700M
YoY Change	167.47%	61.7%	70.0%
Accrued Expenses	$3.767M	$5.900M	$4.500M
YoY Change	-16.29%	96.67%	50.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$4.000K	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Short-Term Liabilities	$9.186M	$16.56M	$16.60M
YoY Change	-44.66%	81.88%	82.42%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$6.309M	$7.100M	$7.100M
YoY Change	-11.14%	-8.97%	-8.97%
Total Long-Term Liabilities	$6.309M	$7.100M	$7.100M
YoY Change	-11.14%	-8.97%	-8.97%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.186M	$16.56M	$16.60M
Total Long-Term Liabilities	$6.309M	$7.100M	$7.100M
Total Liabilities	$15.50M	$23.67M	$23.70M
YoY Change	-34.62%	39.93%	40.24%
SHAREHOLDERS EQUITY
Retained Earnings		-$442.5M
YoY Change		7.11%
Common Stock		$546.6M
YoY Change		23.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$64.63M	$104.1M	$104.1M
YoY Change
Total Liabilities & Shareholders Equity	$80.12M	$127.7M	$127.7M
YoY Change	-37.26%	171.82%	171.7%

Cashflow Statement

Concept	2021	2020 Q4	2020
OPERATING ACTIVITIES
Net Income	-$51.59M	-$11.87M	-$29.37M
YoY Change	75.65%	84.03%	18.09%
Depreciation, Depletion And Amortization	$400.0K	$110.0K	$500.0K
YoY Change	-20.0%	-15.38%	-16.67%
Cash From Operating Activities	-$50.20M	-$7.130M	-$21.39M
YoY Change	134.63%	4.7%	-9.6%
INVESTING ACTIVITIES
Capital Expenditures	$16.00K	-$30.00K	$27.00K
YoY Change	-40.74%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$3.500M
YoY Change	-100.0%	-100.0%	-86.32%
Cash From Investing Activities	-$16.00K	-$30.00K	$3.473M
YoY Change	-100.46%	-100.25%	-86.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$7.948M		$101.0M
YoY Change	-92.13%		879.54%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	7.734M	3.880M	95.02M
YoY Change	-91.86%	-281.31%	-3905.37%
NET CHANGE
Cash From Operating Activities	-50.20M	-7.130M	-21.39M
Cash From Investing Activities	-16.00K	-30.00K	3.473M
Cash From Financing Activities	7.734M	3.880M	95.02M
Net Change In Cash	-42.48M	-3.280M	77.10M
YoY Change	-155.1%	-207.89%	-13370.05%
FREE CASH FLOW
Cash From Operating Activities	-$50.20M	-$7.130M	-$21.39M
Capital Expenditures	$16.00K	-$30.00K	$27.00K
Free Cash Flow	-$50.21M	-$7.100M	-$21.42M
YoY Change	134.41%	4.26%	-9.49%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	163293296
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	127623859
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	163293296
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	127623859
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020	trvn	Difference Between Basic And Diluted Net Loss Per Share DifferenceBetweenBasicAndDilutedNetLossPerShare	0.00
CY2021	trvn	Difference Between Basic And Diluted Net Loss Per Share DifferenceBetweenBasicAndDilutedNetLossPerShare	0.00
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	159999917
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.trevenainc.com/20211231#LeaseLiabilityCurrent
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.trevenainc.com/20211231#LeaseLiabilityCurrent
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://www.trevenainc.com/20211231#LeaseLiabilityNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://www.trevenainc.com/20211231#LeaseLiabilityNoncurrent
CY2020Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.trevenainc.com/20211231#LeaseLiabilityCurrent
CY2021Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.trevenainc.com/20211231#LeaseLiabilityCurrent
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://www.trevenainc.com/20211231#LeaseLiabilityNoncurrent
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://www.trevenainc.com/20211231#LeaseLiabilityNoncurrent
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001429560
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Entity Registrant Name EntityRegistrantName	TREVENA INC
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	165520007
CY2020Q4	us-gaap	Loans Payable LoansPayable	0
CY2021Q4	us-gaap	Loans Payable LoansPayable	0
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-36193
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1469215
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	955 Chesterbrook Blvd.
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 110
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Chesterbrook
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19087
CY2021	dei	City Area Code CityAreaCode	610
CY2021	dei	Local Phone Number LocalPhoneNumber	354-8840
CY2021	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2021	dei	Trading Symbol TradingSymbol	TRVN
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Auditor Location AuditorLocation	Philadelphia, Pennsylvania
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	66923000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	109403000
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	71000
CY2021Q4	us-gaap	Inventory Net InventoryNet	2352000
CY2020Q4	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	9000000
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	276000000.0
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	165520007
CY2021	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1448000
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	570000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	70723000
CY2020Q4	us-gaap	Assets Current AssetsCurrent	119044000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1311000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1310000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1841000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2253000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4706000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5119000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1543000
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13000
CY2021Q4	us-gaap	Assets Assets	80124000
CY2020Q4	us-gaap	Assets Assets	127739000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4547000
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1693000
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	3847000
CY2020Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	5168000
CY2020Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	9000000
CY2021Q4	trvn	Lease Liability Current LeaseLiabilityCurrent	792000
CY2020Q4	trvn	Lease Liability Current LeaseLiabilityCurrent	703000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9186000
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16564000
CY2021Q4	trvn	Lease Liability Noncurrent LeaseLiabilityNoncurrent	6309000
CY2020Q4	trvn	Lease Liability Noncurrent LeaseLiabilityNoncurrent	7101000
CY2020Q4	trvn	Preferred Stock Warrant Liability Non Current PreferredStockWarrantLiabilityNonCurrent	6000
CY2021Q4	us-gaap	Liabilities Liabilities	15495000
CY2020Q4	us-gaap	Liabilities Liabilities	23671000
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	165520007
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	159999917
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	165000
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	160000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	558566000
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	546422000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-494102000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-442514000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	64629000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	104068000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	80124000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	127739000
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	567000
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3069000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	954000
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	182000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	38112000
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19248000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13426000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13124000
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	52492000
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	32554000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-51925000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-29485000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6000
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	172000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	206000
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	162000
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	240000
CY2021	us-gaap	Interest Expense InterestExpense	1000
CY2020	us-gaap	Interest Expense InterestExpense	29000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-2000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	337000
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	416000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-51588000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-29069000
CY2020	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	300000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-51588000
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-29369000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	163293296
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	127623859
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	30078000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	3284000
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	136000
CY2020	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-1071000
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	101010000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-29369000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	104068000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	4407000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	187000
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-393000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7948000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-51588000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	64629000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-51588000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-29369000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	428000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	477000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	4407000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	3284000
CY2020	us-gaap	Paid In Kind Interest PaidInKindInterest	8000
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-2000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6000
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1000
CY2021	trvn	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	-413000
CY2020	trvn	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	-353000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2337000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1049000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2352000
CY2021	us-gaap	Increase Decrease In Insurance Settlements Receivable IncreaseDecreaseInInsuranceSettlementsReceivable	-9000000
CY2021	trvn	Increase Decrease In Litigation Reserve IncreaseDecreaseInLitigationReserve	-9000000
CY2021	trvn	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-695000
CY2020	trvn	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-610000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1533000
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3411000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-50197000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21394000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27000
CY2020	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	3500000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3473000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	187000
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	136000
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7948000
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	101010000
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	393000
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1071000
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	8000
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	10000
CY2020	us-gaap	Repayments Of Debt RepaymentsOfDebt	5045000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7734000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	95020000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-42479000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	77099000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	110713000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33614000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	68234000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	110713000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	19000
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-494100000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-51600000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-29400000
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Management used significant estimates in the following areas, among others: stock-based compensation expense, the determination of the </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">fair value of stock-based awards, the fair value of common stock warrants, the accounting for research and development costs, accrued expenses and the recoverability of the Company’s net deferred tax assets and related valuation allowance. The financial data and other information disclosed in these notes are not necessarily indicative of the results to be expected for any future year or period. The Company bases its estimates on historical experience and also on assumptions that it believes are reasonable, however, actual results could significantly differ from those results.</p>
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2081000
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1000
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk are primarily cash, cash equivalents, and restricted cash. The Company’s investment policy includes guidelines on the quality of the institutions and financial instruments and defines allowable investments that the Company believes minimizes the exposure to concentration of credit risk. The Company has no off-balance sheet concentrations of credit risk such as foreign currency exchange contracts, option contracts or other hedging arrangements.</p>
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4334000
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4334000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2493000
CY2021	trvn	Number Of Stock Based Compensation Plans NumberOfStockBasedCompensationPlans	2
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1841000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2253000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	400000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	500000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2132000
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2919000
CY2021Q4	trvn	Accrued Commercial Expenses Current AccruedCommercialExpensesCurrent	107000
CY2020Q4	trvn	Accrued Commercial Expenses Current AccruedCommercialExpensesCurrent	605000
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	124000
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	784000
CY2021Q4	trvn	Accrued Clinical Trial Fees Current AccruedClinicalTrialFeesCurrent	550000
CY2021Q4	trvn	Accrued Development Expenses Current AccruedDevelopmentExpensesCurrent	161000
CY2020Q4	trvn	Accrued Development Expenses Current AccruedDevelopmentExpensesCurrent	413000
CY2021Q4	trvn	Accrued Credit Balances To Customers AccruedCreditBalancesToCustomers	87000
CY2021Q4	trvn	Accrued Purchases Current AccruedPurchasesCurrent	271000
CY2021Q4	trvn	Other Accrued Expenses And Other Current Liabilities OtherAccruedExpensesAndOtherCurrentLiabilities	415000
CY2020Q4	trvn	Other Accrued Expenses And Other Current Liabilities OtherAccruedExpensesAndOtherCurrentLiabilities	447000
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	3847000
CY2020Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	5168000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4407000
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3284000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4000
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	7000
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	4000
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	4000
CY2020Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	11000
CY2021	trvn	Accounts Receivable Credit Loss Sales Discounts Provision Related To Current Period Sales AccountsReceivableCreditLossSalesDiscountsProvisionRelatedToCurrentPeriodSales	14000
CY2021Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	19122102
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4706000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5119000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	788000
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	696000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6309000
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7097000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	7097000
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	7793000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	1228000
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	1256000
CY2021	us-gaap	Sublease Income SubleaseIncome	1186000
CY2020	us-gaap	Sublease Income SubleaseIncome	1195000
CY2021	trvn	Operating Lease Income Expense Net OperatingLeaseIncomeExpenseNet	42000
CY2020	trvn	Operating Lease Income Expense Net OperatingLeaseIncomeExpenseNet	61000
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	7000
CY2020	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	9000
CY2021	trvn	Accounts Receivable Credit Loss Chargebacks Provision Related To Current Period Sales AccountsReceivableCreditLossChargebacksProvisionRelatedToCurrentPeriodSales	37000
CY2020	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1000
CY2021	trvn	Finance Lease Cost FinanceLeaseCost	8000
CY2020	trvn	Finance Lease Cost FinanceLeaseCost	10000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	265000
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	179000
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	8000
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	10000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1401000
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	4000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1425000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1450000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1474000
CY2021Q4	trvn	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	3661000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	9411000
CY2021Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	4000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2314000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	7097000
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	4000
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	1118000
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	1139000
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	996000
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	3253000
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y
CY2020Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.092
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.092
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.065
CY2020Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.065
CY2020Q4	trvn	Accounts Receivable Allowance For Credit Loss Sales Discounts AccountsReceivableAllowanceForCreditLossSalesDiscounts	2000
CY2020Q4	trvn	Accounts Receivable Allowance For Credit Loss Chargebacks AccountsReceivableAllowanceForCreditLossChargebacks	5000
CY2020Q4	trvn	Accounts Receivable Allowance For Credit Loss Fee For Service AccountsReceivableAllowanceForCreditLossFeeForService	10000
CY2021	trvn	Accounts Receivable Credit Loss Fee For Service Provision Related To Current Period Sales AccountsReceivableCreditLossFeeForServiceProvisionRelatedToCurrentPeriodSales	83000
CY2021	trvn	Accounts Receivable Credit Loss Sales Discounts Credit Or Payments Made During Period AccountsReceivableCreditLossSalesDiscountsCreditOrPaymentsMadeDuringPeriod	15000
CY2021	trvn	Accounts Receivable Credit Loss Chargebacks Credit Or Payments Made During Period AccountsReceivableCreditLossChargebacksCreditOrPaymentsMadeDuringPeriod	1000
CY2021	trvn	Accounts Receivable Credit Loss Fee For Service Credit Or Payments Made During Period AccountsReceivableCreditLossFeeForServiceCreditOrPaymentsMadeDuringPeriod	48000
CY2021Q4	trvn	Accounts Receivable Allowance For Credit Loss Sales Discounts AccountsReceivableAllowanceForCreditLossSalesDiscounts	1000
CY2021Q4	trvn	Accounts Receivable Allowance For Credit Loss Chargebacks AccountsReceivableAllowanceForCreditLossChargebacks	41000
CY2021Q4	trvn	Accounts Receivable Allowance For Credit Loss Fee For Service AccountsReceivableAllowanceForCreditLossFeeForService	45000
CY2021Q4	trvn	Accounts Receivable Allowance For Credit Loss AccountsReceivableAllowanceForCreditLoss	87000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	14920000
CY2021Q4	trvn	Deferred Tax Assets Research And Development Expenses Capitalized For Tax Purposes DeferredTaxAssetsResearchAndDevelopmentExpensesCapitalizedForTaxPurposes	93254000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-51588000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-29369000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	163293296
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	127623859
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2020Q4	trvn	Deferred Tax Assets Research And Development Expenses Capitalized For Tax Purposes DeferredTaxAssetsResearchAndDevelopmentExpensesCapitalizedForTaxPurposes	93812000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3960000
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	18643796
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13631452
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	300000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	300000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	14400000
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	5900000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	40810000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	25949000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	15575000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4130000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	691000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	772000
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	312000
CY2020Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	246000
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	657000
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	730000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	155259000
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	140559000
CY2021Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	381000
CY2020Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	119000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	381000
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	119000
CY2021Q4	trvn	Deferred Tax Assets Liabilities Net Before Valuation Allowance DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance	154878000
CY2020Q4	trvn	Deferred Tax Assets Liabilities Net Before Valuation Allowance DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance	140440000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	154878000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	140440000
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.002
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.010
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.072
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.048
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.013
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.026
CY2021	trvn	Effective Income Tax Rate Reconciliation Withholding Tax Percent EffectiveIncomeTaxRateReconciliationWithholdingTaxPercent	0
CY2020	trvn	Effective Income Tax Rate Reconciliation Withholding Tax Percent EffectiveIncomeTaxRateReconciliationWithholdingTaxPercent	-0.010
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.014
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.069
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.001
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.023
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.280
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.202
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.010
CY2021	trvn	Defined Contribution Plan Employer Matching Contribution Percent Of Match For First Eligible Contributions DefinedContributionPlanEmployerMatchingContributionPercentOfMatchForFirstEligibleContributions	1
CY2021	trvn	Defined Contribution Plan Employer Match Employee Contribution Level One DefinedContributionPlanEmployerMatchEmployeeContributionLevelOne	0.03
CY2021	trvn	Defined Contribution Plan Employer Matching Contribution Percent Of Match For Second Eligible Contributions DefinedContributionPlanEmployerMatchingContributionPercentOfMatchForSecondEligibleContributions	0.50
CY2021	trvn	Defined Contribution Plan Employer Match Employee Contribution Level Two DefinedContributionPlanEmployerMatchEmployeeContributionLevelTwo	0.02
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	300000
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	300000
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	200000
CY2021	dei	Auditor Firm AuditorFirmId	42

Files In Submission

Name	View Source	Status
0001558370-22-004825-index-headers.html	Edgar Link	pending
0001558370-22-004825-index.html	Edgar Link	pending
0001558370-22-004825.txt	Edgar Link	pending
0001558370-22-004825-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
trvn-20211231.xsd	Edgar Link	pending
trvn-20211231x10k.htm	Edgar Link	pending
trvn-20211231x10k003.jpg	Edgar Link	pending
trvn-20211231x10k_htm.xml	Edgar Link	completed
trvn-20211231xex23d1.htm	Edgar Link	pending
trvn-20211231xex31d1.htm	Edgar Link	pending
trvn-20211231xex31d2.htm	Edgar Link	pending
trvn-20211231xex32d1.htm	Edgar Link	pending
trvn-20211231xex32d2.htm	Edgar Link	pending
trvn-20211231_cal.xml	Edgar Link	unprocessable
trvn-20211231_def.xml	Edgar Link	unprocessable
trvn-20211231_lab.xml	Edgar Link	unprocessable
trvn-20211231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TRVN
TREVENA INC Stock $trvn

2021 Form 10-K Financial Statement

#000155837022004825 Filed on March 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRVN TREVENA INC Stock $trvn

2021 Form 10-K Financial Statement

#000155837022004825 Filed on March 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRVN
TREVENA INC Stock $trvn